Dear Editor: I read with interest the Risk Management column “Terminating the treatment relationship,” in the January issue of Psychiatry 2010 [Psychiatry (Edgemont) 2010;7(1):40–42]. When it comes to terminating a
by Elisa Cascade; Amir H. Kalali, MD; and Sharon B. Wigal, PhD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Ashley B. Johnson, DO; Julie P. Gentile, MD; and Terry L. Correll, DO Dr. Johnson is a Fourth Year Resident, Department of Psychiatry, Boonshoft School of Medicine, Wright State
by David R. Spiegel, MD; Lindsay Holtz, MD; and Kokil Chopra, MBBS Drs. Spiegel, Holtz, and Chopra are from Eastern Virginia Medical School, Norfolk, Virginia. Psychiatry (Edgemont) 2010;7(4):31–36
by Andrew Donohue, DO Dr. Donohue is a Forensic Psychiatrist, Delaware Psychiatric Center, New Castle, Delaware. Psychiatry (Edgemont) 2010;7(4):37–39
Dear Colleagues: Welcome to the March issue of Psychiatry 2010. In this month’s “Trend Watch,” the authors explore the penetration of generic atypical antipsychotics in the United States market before
by Susan Lenderts, BA; Amir H. Kalali, MD; and Peter Buckley, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Richard D. Sanders, MD, and Paulette Marie Gillig, MD, PhD Dr. Sanders is Associate Professor, Departments of Psychiatry and Neurology, Boonshoft School of Medicine, Wright State University, and Ohio
by Nuno Borja-Santos, MD, MSc; Bruno Trancas, MD; Pilar Santos Pinto, MD; Bárbara Lopes, MD; António Gamito, MD; Sandra Almeida, MD; Berta Ferreira, MD; Antonio Luengo, MD; Carlos Vieira, MD;
by Devavrat Joshi, Md; Sharad Koirala, MD; Sachin Lamichhane, MD; Anubha Paladugu, MD; Rupinder Johal, MD; and Steven Lippmann, MD Drs. Joshi, Koirala, and Lamichhane are from the Mental Hospital
by Assad Meymandi, MD, PhD, DLFAPA Dr. Meymandi is in private practice as a psychiatrist and neurologist and serves as an adjunct professor of psychiatry at the University of North
Dear Colleagues: Welcome to the February issue of Psychiatry 2010. As you are all very aware, the recent study in JAMA by Fournier et al on antidepressant drug effects and
by Susan Lenderts, BA; Amir H. Kalali, MD; and Richard Weisler, MD Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Imran S. Khawaja, MD, and Joseph J. Westermeyer, MD, PhD Dr. Khawaja is Assistant Professor of Psychiatry, University of Minnesota School of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota;
Parikshit Deshmukh, MD; Guarav Kulkarni, MD; and Drew Barzman, MD Dr. Deshmukh is a resident with the Division of Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio; Dr. Kulkarni is
Thinking Things Through: The Science of Mind
by Assad Meymandi, MD, PhD, DLFAPA Dr. Meymandi is in private practice as a psychiatrist and neurologist and serves as an adjunct professor of psychiatry at the University of North
Read More